The duration of type 2 diabetes is increasing owing to the global trend towards obesity and younger age of onset. In all patients with diabetes, regardless of type, the risk of developing complications is strongly related to disease duration and glycaemic control. People with diabetes need close screening and regular follow up to reduce their complication burden.
- Diabetes poses a significant health burden and has considerable impact on the healthcare system.
- Screening for microvascular and macrovascular complications is recommended for people with either type 1 or type 2 diabetes.
- People with type 1 diabetes should be screened for associated autoimmune conditions.
- Treatment targets, especially glycated haemoglobin level (HbA1c), should be individualised, taking into account relative risk and potential adverse effects.